세계의 의약품 재이용 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2033년)
Global Drug Repurposing Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033
상품코드:1820662
리서치사:Value Market Research
발행일:2025년 07월
페이지 정보:영문 132 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 의약품 재이용 시장은 크게 성장하고 있으며, 2024년 355억 1,000만 달러에서 2033년에는 550억 달러에 이를 전망입니다. 이 확대는 2025-2033년 연평균 복합 성장률(CAGR) 4.98%로 성장할 것으로 예측됩니다.
세계의 의약품 재이용 시장은 의약품 개발의 신속화, 비용 절감, 언메트 메디컬 니즈에의 대응 등의 요구를 배경으로 큰 성장을 이루고 있습니다. 의약품 재사용은 알려진 안전성 프로파일을 활용하면서 기존 약물의 새로운 치료 용도를 확인합니다. 향후 개발에서는 AI를 활용한 창약, 빅데이터 분석, 유전체 프로테옴 데이터와의 통합이 주목됩니다.
또한 만성 및 희귀질환 증가로 재사용 기회가 확대되고 있습니다. 규제 프레임워크은 승인 경로를 촉진하기 위해 진화하고 있습니다. 공동 연구 및 관민 파트너십이 혁신을 가속화하고 있습니다. 의약품 연구개발의 변화에 따라 의약품 재이용 시장도 혁신을 계속해 보다 빠르고 비용 효율적이고 안전한 치료 솔루션을 제공해 나갈 것입니다.
목차
제1장 서문
제2장 주요 요약
시장의 하이라이트
세계 시장 현황
제3장 의약품 재이용 : 산업 분석
서문 : 시장 역학
시장 성장 촉진요인
시장 성장 억제요인
기회
업계 동향
Porter's Five Forces 분석
시장 매력 분석
제4장 밸류체인 분석
밸류체인 분석
원재료 분석
원재료 리스트
원재료 제조업체 리스트
주요 원재료의 가격 동향
잠재적 구매자 목록
마케팅 채널
직접 마케팅
간접 마케팅
마케팅 채널 발전 동향
제5장 세계의 의약품 재이용 시장 분석 : 적응 질환별
개요 : 적응 질환별
과거 및 예측 데이터 분석 : 적응 질환별
암 영역
중추 신경계 질환
신경퇴행성 질환
기타(희귀질환 등)
제6장 세계의 의약품 재이용 시장 분석 : 접근 유형별
개요 : 접근 유형별
과거 및 예측 데이터 분석 : 접근 유형별
질병 중심 접근
타겟 중심 접근
약물 중심 접근
제7장 세계의 의약품 재이용 시장 분석 : 최종 사용자별
개요 : 최종 사용자별
과거 및 예측 데이터 분석 : 최종 사용자별
병원 및 클리닉
외래수술센터(ASC)
기타(연구기관 등)
제8장 세계의 의약품 재이용 시장 분석 : 지역별
지역별 전망
서문
북미의 매출 분석
개요, 분석 및 예측
북미 : 부문별
북미 국가별
미국
캐나다
멕시코
유럽의 매출 분석
개요, 분석 및 예측
유럽 : 부문별
유럽 국가별
영국
프랑스
독일
이탈리아
러시아
기타 유럽
아시아태평양의 매출 분석
개요, 분석 및 예측
아시아태평양 : 부문별
아시아태평양 국가별
중국
인도
일본
한국
호주
동남아시아
기타 아시아태평양
라틴아메리카의 매출 분석
개요, 분석 및 예측
라틴아메리카 : 부문별
라틴아메리카 국가별
브라질
아르헨티나
페루
칠레
기타 라틴아메리카
중동 및 아프리카의 매출 분석
개요, 분석 및 예측
중동 및 아프리카 : 부문별
중동 및 아프리카 국가별 일람
사우디아라비아
아랍에미리트(UAE)
이스라엘
남아프리카
기타 중동 및 아프리카
제9장 의약품 재이용 기업 경쟁 구도
의약품 재이용 시장의 경쟁
제휴, 협력 및 합의
합병 및 인수
신제품 출시
기타 개발
제10장 기업 프로파일
주요 기업의 시장 점유율 분석
시장 집중도
Algernon Pharmaceuticals
Biovista Inc.
Celentyx Ltd.
ChemBio Discovery Inc.
Chord Therapeutics SA
Excelra
Fios Genomics Ltd.
Lantern Pharma Inc.
Novartis AG
Paradigm Biopharmaceuticals Limited
Predictive Oncology
Segue Therapeutics LLC
Teva Pharmaceutical Industries Ltd
AJY
영문 목차
영문목차
Global Drug Repurposing Market is poised to witness substantial growth, reaching a value of USD 55 Billion by the year 2033, up from USD 35.51 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 4.98% between 2025 and 2033.
The global drug repurposing market is poised for significant growth driven by the need to accelerate drug development, reduce costs, and address unmet medical needs. Drug repurposing identifies new therapeutic uses for existing drugs, leveraging known safety profiles. Future developments will focus on AI-driven drug discovery, big data analytics, and integration with genomic and proteomic data.
Moreover, increasing prevalence of chronic and rare diseases is expanding repurposing opportunities. Regulatory frameworks are evolving to facilitate approval pathways. Collaborative research and public-private partnerships are accelerating innovation. As pharmaceutical R&D transforms, the drug repurposing market will continue to innovate, delivering faster, cost-effective, and safer therapeutic solutions.
Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:
Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.
Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.
Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.
Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.
Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.
Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.
Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.
LIST OF SEGMENTS COVERED
This section of the Drug Repurposing market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
3.7.1 Market Attractiveness Analysis By Disease Indication
3.7.2 Market Attractiveness Analysis By Approach Type
3.7.3 Market Attractiveness Analysis By End User
3.7.4 Market Attractiveness Analysis By Regions
4. VALUE CHAIN ANALYSIS
4.1. Value Chain Analysis
4.2. Raw Material Analysis
4.2.1 List of Raw Materials
4.2.2 Raw Material Manufactures List
4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1 Direct Marketing
4.4.2 Indirect Marketing
4.4.3 Marketing Channel Development Trend
5. GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY DISEASE INDICATION
5.1. Overview By Disease Indication
5.2. Historical and Forecast Data Analysis By Disease Indication
5.3. Oncology Historic and Forecast Sales By Regions
5.4. CNS Diseases Historic and Forecast Sales By Regions
5.5. Neurodegenerative Diseases Historic and Forecast Sales By Regions
5.6. Others (Rare Disorders, etc.) Historic and Forecast Sales By Regions
6. GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY APPROACH TYPE
6.1. Overview By Approach Type
6.2. Historical and Forecast Data Analysis By Approach Type
6.3. Disease-centric Approach Historic and Forecast Sales By Regions
6.4. Target-centric Approach Historic and Forecast Sales By Regions
6.5. Drug-centric Approach Historic and Forecast Sales By Regions
7. GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY END USER
7.1. Overview By End User
7.2. Historical and Forecast Data Analysis By End User
7.3. Hospitals & Clinics Historic and Forecast Sales By Regions
7.4. Ambulatory Surgery Centers Historic and Forecast Sales By Regions
7.5. Others (Research Institutes, etc.) Historic and Forecast Sales By Regions
8. GLOBAL DRUG REPURPOSING MARKET ANALYSIS BY GEOGRAPHY
8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
8.3.1 Overview, Historic and Forecast Data Sales Analysis
8.3.2 North America By Segment Sales Analysis
8.3.3 North America By Country Sales Analysis
8.3.4 United States Sales Analysis
8.3.5 Canada Sales Analysis
8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
8.4.1 Overview, Historic and Forecast Data Sales Analysis
8.4.2 Europe By Segment Sales Analysis
8.4.3 Europe By Country Sales Analysis
8.4.4 United Kingdom Sales Analysis
8.4.5 France Sales Analysis
8.4.6 Germany Sales Analysis
8.4.7 Italy Sales Analysis
8.4.8 Russia Sales Analysis
8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
8.5.1 Overview, Historic and Forecast Data Sales Analysis
8.5.2 Asia Pacific By Segment Sales Analysis
8.5.3 Asia Pacific By Country Sales Analysis
8.5.4 China Sales Analysis
8.5.5 India Sales Analysis
8.5.6 Japan Sales Analysis
8.5.7 South Korea Sales Analysis
8.5.8 Australia Sales Analysis
8.5.9 South East Asia Sales Analysis
8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
8.6.1 Overview, Historic and Forecast Data Sales Analysis
8.6.2 Latin America By Segment Sales Analysis
8.6.3 Latin America By Country Sales Analysis
8.6.4 Brazil Sales Analysis
8.6.5 Argentina Sales Analysis
8.6.6 Peru Sales Analysis
8.6.7 Chile Sales Analysis
8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
8.7.1 Overview, Historic and Forecast Data Sales Analysis
8.7.2 Middle East & Africa By Segment Sales Analysis
8.7.3 Middle East & Africa By Country Sales Analysis
8.7.4 Saudi Arabia Sales Analysis
8.7.5 UAE Sales Analysis
8.7.6 Israel Sales Analysis
8.7.7 South Africa Sales Analysis
8.7.8 Rest Of Middle East And Africa Sales Analysis
9. COMPETITIVE LANDSCAPE OF THE DRUG REPURPOSING COMPANIES
9.1. Drug Repurposing Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments
10. COMPANY PROFILES OF DRUG REPURPOSING INDUSTRY
10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Algernon Pharmaceuticals
10.3.1 Company Overview
10.3.2 Company Revenue
10.3.3 Products
10.3.4 Recent Developments
10.4. Biovista Inc.
10.4.1 Company Overview
10.4.2 Company Revenue
10.4.3 Products
10.4.4 Recent Developments
10.5. Celentyx Ltd.
10.5.1 Company Overview
10.5.2 Company Revenue
10.5.3 Products
10.5.4 Recent Developments
10.6. ChemBio Discovery Inc.
10.6.1 Company Overview
10.6.2 Company Revenue
10.6.3 Products
10.6.4 Recent Developments
10.7. Chord Therapeutics SA
10.7.1 Company Overview
10.7.2 Company Revenue
10.7.3 Products
10.7.4 Recent Developments
10.8. Excelra
10.8.1 Company Overview
10.8.2 Company Revenue
10.8.3 Products
10.8.4 Recent Developments
10.9. Fios Genomics Ltd.
10.9.1 Company Overview
10.9.2 Company Revenue
10.9.3 Products
10.9.4 Recent Developments
10.10. Lantern Pharma Inc.
10.10.1 Company Overview
10.10.2 Company Revenue
10.10.3 Products
10.10.4 Recent Developments
10.11. Novartis AG
10.11.1 Company Overview
10.11.2 Company Revenue
10.11.3 Products
10.11.4 Recent Developments
10.12. Paradigm Biopharmaceuticals Limited
10.12.1 Company Overview
10.12.2 Company Revenue
10.12.3 Products
10.12.4 Recent Developments
10.13. Predictive Oncology
10.13.1 Company Overview
10.13.2 Company Revenue
10.13.3 Products
10.13.4 Recent Developments
10.14. Segue Therapeutics LLC
10.14.1 Company Overview
10.14.2 Company Revenue
10.14.3 Products
10.14.4 Recent Developments
10.15. Teva Pharmaceutical Industries Ltd
10.15.1 Company Overview
10.15.2 Company Revenue
10.15.3 Products
10.15.4 Recent Developments
Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies
